Clinical Trials Browser

Phase 1 × Carcinoma × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all

NCT01671592 2017-09-26

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

Phase 1 Completed

Gastrointestinal

Carcinoma, Neoplasms, Colorectal Neoplasms